_version_ 1784913253211570176
author Gladstone, Douglas E
D'Alessio, Franco
Howard, Christopher
Lyu, Mi-Ae
Mock, Jason R.
Gibbs, Kevin W.
Abrams, Darryl
Huang, Meixian
Zeng, Ke
Herlihy, James P.
Castillo, Sergio T.
Bassett, Roland
Sadeghi, Tara
Parmar, Simrit
Flowers, Christopher R.
Mukherjee, Siddhartha
Schoenfeld, David
Thall, Peter F.
Slutsky, Arthur S.
author_facet Gladstone, Douglas E
D'Alessio, Franco
Howard, Christopher
Lyu, Mi-Ae
Mock, Jason R.
Gibbs, Kevin W.
Abrams, Darryl
Huang, Meixian
Zeng, Ke
Herlihy, James P.
Castillo, Sergio T.
Bassett, Roland
Sadeghi, Tara
Parmar, Simrit
Flowers, Christopher R.
Mukherjee, Siddhartha
Schoenfeld, David
Thall, Peter F.
Slutsky, Arthur S.
author_sort Gladstone, Douglas E
collection PubMed
description
format Online
Article
Text
id pubmed-10043947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-100439472023-03-28 Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS Gladstone, Douglas E D'Alessio, Franco Howard, Christopher Lyu, Mi-Ae Mock, Jason R. Gibbs, Kevin W. Abrams, Darryl Huang, Meixian Zeng, Ke Herlihy, James P. Castillo, Sergio T. Bassett, Roland Sadeghi, Tara Parmar, Simrit Flowers, Christopher R. Mukherjee, Siddhartha Schoenfeld, David Thall, Peter F. Slutsky, Arthur S. Blood Adv Research Letter The American Society of Hematology 2023-03-28 /pmc/articles/PMC10043947/ /pubmed/36961352 http://dx.doi.org/10.1182/bloodadvances.2022009619 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Gladstone, Douglas E
D'Alessio, Franco
Howard, Christopher
Lyu, Mi-Ae
Mock, Jason R.
Gibbs, Kevin W.
Abrams, Darryl
Huang, Meixian
Zeng, Ke
Herlihy, James P.
Castillo, Sergio T.
Bassett, Roland
Sadeghi, Tara
Parmar, Simrit
Flowers, Christopher R.
Mukherjee, Siddhartha
Schoenfeld, David
Thall, Peter F.
Slutsky, Arthur S.
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title_full Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title_fullStr Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title_full_unstemmed Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title_short Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
title_sort randomized, double-blinded, placebo-controlled trial of allogeneic cord blood t-regulatory cells for treatment of covid-19 ards
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043947/
https://www.ncbi.nlm.nih.gov/pubmed/36961352
http://dx.doi.org/10.1182/bloodadvances.2022009619
work_keys_str_mv AT gladstonedouglase randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT dalessiofranco randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT howardchristopher randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT lyumiae randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT mockjasonr randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT gibbskevinw randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT abramsdarryl randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT huangmeixian randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT zengke randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT herlihyjamesp randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT castillosergiot randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT bassettroland randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT sadeghitara randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT parmarsimrit randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT flowerschristopherr randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT mukherjeesiddhartha randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT schoenfelddavid randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT thallpeterf randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards
AT slutskyarthurs randomizeddoubleblindedplacebocontrolledtrialofallogeneiccordbloodtregulatorycellsfortreatmentofcovid19ards